Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

GP-Act III Acquisition (GPAT) EBITDA (2023 - 2025)

GP-Act III Acquisition (GPAT) has disclosed EBITDA for 3 consecutive years, with -$84204.0 as the latest value for Q4 2025.

  • Quarterly EBITDA rose 54.33% to -$84204.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$551918.0 through Dec 2025, up 2.31% year-over-year, with the annual reading at -$551918.0 for FY2025, 2.31% up from the prior year.
  • EBITDA for Q4 2025 was -$84204.0 at GP-Act III Acquisition, up from -$126328.0 in the prior quarter.
  • The five-year high for EBITDA was -$616.0 in Q3 2023, with the low at -$200052.0 in Q1 2025.
  • Average EBITDA over 3 years is -$102748.4, with a median of -$126328.0 recorded in 2025.
  • The sharpest move saw EBITDA tumbled 28654.29% in 2024, then soared 54.33% in 2025.
  • GP-Act III Acquisition's EBITDA stood at -$12108.0 in 2023, then crashed by 1422.62% to -$184359.0 in 2024, then soared by 54.33% to -$84204.0 in 2025.
  • Per Business Quant, the three most recent readings for GPAT's EBITDA are -$84204.0 (Q4 2025), -$126328.0 (Q3 2025), and -$141334.0 (Q2 2025).